Remove Digital Health Remove healthcare technology Remove Leadership Remove Pharmaceuticals
article thumbnail

Average Multiples and Key Drivers of Digital Therapeutics (DTx) M&A deals in 2023

Lloyd Price

This is due to a number of factors, including: The increasing prevalence of chronic diseases The rising cost of healthcare The increasing demand for patient-centered care As a result, DTx companies are still expected to be attractive targets for M&A deals. The average deal size for DTx M&A deals is increasing. Subscribe Today!

article thumbnail

Abu Dhabi Global Healthcare Week: What are the key talking points likely to be?

Lloyd Price

In addition to these core areas, there will likely be discussions on specific sectors within healthcare, such as pharmaceuticals, medical management, and healthcare delivery models. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Colin Bower Joins VivoSense as Chief Executive Officer

Digital Health Global

“He has consistently worked to improve the speed, safety, and cost-effectiveness of clinical trials through the adoption of new technological solutions. Colin has demonstrated strong leadership to his teams and customers alike.” “I Colin is a proven leader with a deep understanding of the digital health technology industry.

BioTech 88
article thumbnail

PointClickCare Announces Brian Drozdowicz as Senior Vice President and General Manager of Acute & Payer Markets

Digital Health Global

In his role, Brian will serve as an important member of the senior leadership team, responsible for the development and continued success of Health System, Health Plan and Convener markets, and for driving value in PointClickCare’s connected care network. health plan across the U.S,

article thumbnail

Where are HealthTech's soft landing M&A deals in today's market?

Lloyd Price

They might target smaller, innovative companies with niche solutions or complementary technologies at reasonable valuations. Traditional healthcare players: Hospitals, insurers, and pharmaceutical companies are increasingly acquiring healthtech startups to improve efficiency, patient engagement, and data-driven decision making.

article thumbnail

Morgan Stanley Global Healthcare Conference Jan 2024: What are the key talking points likely to be?

Lloyd Price

The impact of digital health: Digital health technologies are transforming the way healthcare is delivered. The conference is likely to feature discussions on the latest digital health trends, as well as the impact of digital health on the pharmaceutical industry and the overall healthcare system.

article thumbnail

Scotland's Pioneering Spirit: A Legacy of Medical and Healthcare Innovation

Lloyd Price

Exec Summary: Scotland has emerged as a global leader in the field of digital health and care, driven by a combination of factors: A strong foundation in medical innovation: Scotland boasts a rich history of medical breakthroughs, from the world's first cloned sheep (Dolly) to pioneering research in stem cell therapy.